Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Lexington Biosciences Inc (OTC: LXGTF).

Full DD Report for LXGTF

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-120.07810.08050.08050.07811,540
2018-12-110.08470.080.08470.074725,302
2018-12-100.0680.08010.08010.066252,391
2018-12-07N/A0.0776N/AN/A130
2018-12-060.081950.07760.08390.0754,465

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1114,50225,30257.3156Short
2018-12-105,10052,3919.7345Cover
2018-12-07130130100.0000Short
2018-12-067,15054,46513.1277Cover
2018-12-0448,54784,25457.6198Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on LXGTF.


About Lexington Biosciences Inc (OTC: LXGTF)

Logo for Lexington Biosciences Inc (OTC: LXGTF)

Lexington Biosciences is a medical device company that is developing the HeartSentry, a new non invasive diagnostic device to measure and monitor cardiovascular health by assessing the function of a person s vascular endothelium the vital innermost lining of a person s cardiovascular system. Traditionally, this has only been measured using ultrasound and other complex, difficult to use technologies. The HeartSentry technology core research was created at the University of California Berkeley over a fifteen year period involving many studies and product iterations resulting in a portfolio of multiple pending and issued patents licensed to the company. The company is in the final stages of releasing the developed product for clinical studies. The aim is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person s cardiovascular health. Lexington is engaged with the US FDA and other regulatory agencies on the required product approvals for the HeartSentry.

 

 

 

Current Management

  • Eric Willis / President, CEO, Corporate Secretary
  • Nick Furber / CFO
  • Victoria Bantz / Legal Counsel
  • Doug Janzen / Chairman, Independent Director, Audit Committee Member
  • John Bryan Bryan Disher / Independent Director, Audit Committee Member
    • Bryan Disher CPA,CA spent years with PricewaterhouseCoopers in Canada, Australia and Ukraine. He was admitted to partnership in PwC Canada in and from until his retirement in June was a partner with PwC Central and Eastern Europe, where he served as both Managing Partner of its person Ukrainian practice and leader of its Ukrainian audit and assurance group. Bryan worked in PwC s Mining and Metals practice in Canada and Ukraine, serving both privately held and Canadian and US listed companies. He has assisted companies with initial public offerings and secondary offerings in both Canada and the US, going private transactions, acquisitions, audit, financial reporting and regulatory compliance and filings. Bryan was elected to PwC Canada s Partnership Board in and his years on the Board included a term as Chair of the Board. He was elected to the board of directors of the American Chamber of Commerce in Ukraine, where he served as Chair and ViceChair, and also served on a number of notforprofit boards in Canada.
  • Rocco Rossi / Independent Director, Audit Committee Member
  • Eric Willis /

Current Share Structure

  • Market Cap: $13,297,303 - 03/21/2018
  • Issue and Outstanding: 34,891,901 - 11/30/2017
  • Float: 32,891,901 - 11/30/2017

 


Recent Filings from (OTC: LXGTF)

Supplemental Information - Certificate of Interim Filings - CFO
Filing Type: Supplemental Information - Certificate of Interim Filings - CFOFiling Source: OTC Markets
Filing Date: November, 29 2017
Supplemental Information - Certificate of Interim Filings - CEO
Filing Type: Supplemental Information - Certificate of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: November, 29 2017
Quarterly Report - Management's Discussion and Analysis
Filing Type: Quarterly Report - Management's Discussion and AnalysisFiling Source: OTC Markets
Filing Date: November, 29 2017
Interim Financial Report - Condensed Consolidated Interim Financial Statements
Filing Type: Interim Financial Report - Condensed Consolidated Interim Financial StatementsFiling Source: OTC Markets
Filing Date: November, 29 2017
Supplemental Information - Certificate of Interim Filings - CFO
Filing Type: Supplemental Information - Certificate of Interim Filings - CFOFiling Source: OTC Markets
Filing Date: October, 31 2017
Supplemental Information - Certificate of Interim Filings - CEO
Filing Type: Supplemental Information - Certificate of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: October, 31 2017
Proxy Materials - Notice of Annual General Meeting of Shareholders
Filing Type: Proxy Materials - Notice of Annual General Meeting of ShareholdersFiling Source: OTC Markets
Filing Date: October, 31 2017
Proxy Materials - Form of Proxy for Annual General Meeting
Filing Type: Proxy Materials - Form of Proxy for Annual General MeetingFiling Source: OTC Markets
Filing Date: October, 31 2017
Proxy Materials - Information Circular
Filing Type: Proxy Materials - Information CircularFiling Source: OTC Markets
Filing Date: October, 31 2017
Quarterly Report - Management's Discussion and Analysis
Filing Type: Quarterly Report - Management's Discussion and AnalysisFiling Source: OTC Markets
Filing Date: October, 31 2017

 

 


Daily Technical Chart for (OTC: LXGTF)

Daily Technical Chart for (OTC: LXGTF)


Stay tuned for daily updates and more on (OTC: LXGTF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: LXGTF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in LXGTF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of LXGTF and does not buy, sell, or trade any shares of LXGTF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/